Henry Schein, Inc. (HSIC) Financials

HSIC Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 11.4 billion 6.7 billion
March 31, 2026 11.3 billion 6.5 billion
Dec. 31, 2025 11.2 billion 6.4 billion
Sept. 30, 2025 11.1 billion 6.2 billion

HSIC Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 196.0 million 13.0 million
March 31, 2026 -136.0 million 3.0 million
Dec. 31, 2025 338.0 million 10.0 million
Sept. 30, 2025 141.0 million 13.0 million

HSIC Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 102.0 million
March 31, 2026 112.0 million
Dec. 31, 2025 101.0 million
Sept. 30, 2025 109.0 million

HSIC Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 157.0 million 2.3 billion 351.0 million
March 31, 2026 138.0 million 2.3 billion 341.0 million
Dec. 31, 2025 156.0 million 2.6 billion 251.0 million
Sept. 30, 2025 136.0 million 2.2 billion 264.0 million

HSIC Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 114.4 million
March 31, 2026 116.1 million
Dec. 31, 2025 118.3 million
Sept. 30, 2025 121.0 million

HSIC Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 46.0 million - 831.0 million -
March 31, 2026 39.0 million - 809.0 million -
Dec. 31, 2025 43.0 million - 808.0 million -
Sept. 30, 2025 33.0 million - 752.0 million -

HSIC Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 3.5 billion 2.4 billion
March 31, 2026 3.4 billion 2.3 billion
Dec. 31, 2025 3.4 billion 2.4 billion
Sept. 30, 2025 3.3 billion 2.4 billion

HSIC Revenue by Segment

Graph available only for paid members. Upgrade to see it.

HSIC

Price: $89.77

52 week price:
61.95
92.18

Payout Ratio Range:
-5.21%
33.33%

Earnings Per Share: 3.43 USD

P/E Ratio: 25.68

Exchange: NMS

Sector: Healthcare

Industry: Medical Distribution

Country: United States

Volume: 764242

Ebitda: 296.4 million

Market Capitalization: 10.0 billion

Links: